|
30
|
126
|
7z1cE |
Nanobody h11-b5 and h11-f2 bound to rbd |
|
45
|
194
|
7z1eEEE |
Nanobody h11-h4 q98r h100e bound to rbd |
|
33
|
125
|
7z1bB |
Nanobody h11-a10 and f2 bound to rbd |
|
46
|
196
|
7z1cA |
Nanobody h11-b5 and h11-f2 bound to rbd |
|
44
|
212
|
7wphD |
Sars-cov2 rbd bound to fab06 |
|
36
|
195
|
7wueA |
Crystal structure of sars-cov-2 receptor binding domain in complex with the monoclonal antibody m31a7 |
|
31
|
128
|
7z1aE |
Nanobody h11 and f2 bound to rbd |
|
33
|
125
|
7z1cB |
Nanobody h11-b5 and h11-f2 bound to rbd |
|
46
|
194
|
7tp4Z |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody k398.22 |
|
48
|
231
|
7tp3H |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody k288.2 |
|
48
|
225
|
7tp4H |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody k398.22 |
|
39
|
194
|
7tp3Z |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody k288.2 |
|
49
|
214
|
7tp3L |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody k288.2 |
|
43
|
211
|
7tp4L |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody k398.22 |
|
21
|
106
|
7theC |
Structure of rbd directed antibody dh1042 in complex with sars-cov-2 spike: local refinement of rbd-fab interface |
|
21
|
122
|
7theB |
Structure of rbd directed antibody dh1042 in complex with sars-cov-2 spike: local refinement of rbd-fab interface |
|
40
|
195
|
7theA |
Structure of rbd directed antibody dh1042 in complex with sars-cov-2 spike: local refinement of rbd-fab interface |
|
26
|
231
|
7tc9H |
Locally refined region of sars-cov-2 spike in complex with antibody a19-46.1 |
|
43
|
196
|
7q0gE |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-49 and fi-3a fabs |
|
24
|
216
|
7tc9L |
Locally refined region of sars-cov-2 spike in complex with antibody a19-46.1 |
|
47
|
216
|
7q0gB |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-49 and fi-3a fabs |
|
48
|
218
|
7q0gH |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-49 and fi-3a fabs |
|
51
|
213
|
7ps4C |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-38 |
|
39
|
228
|
7ps4B |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-38 |
|
42
|
195
|
7ps4A |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-38 |
|
15
|
195
|
7tc9B |
Locally refined region of sars-cov-2 spike in complex with antibody a19-46.1 |
|
51
|
220
|
7ps1A |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-27 fab |
|
36
|
183
|
7ps0A |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-24 fabs |
|
41
|
224
|
7ps0B |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-24 fabs |
|
41
|
194
|
7ps1E |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-27 fab |
|
34
|
128
|
7z1bE |
Nanobody h11-a10 and f2 bound to rbd |
|
48
|
194
|
7z1dEEE |
Nanobody h11-h6 bound to rbd |
|
42
|
210
|
7s5pL |
Crystal structure of sars-cov-2 b.1.351 variant receptor binding domain in complex with neutralizing antibody cs23 |
|
49
|
212
|
7s5rL |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibodies cv07-287 and cova1-16 |
|
48
|
212
|
7s5qL |
Crystal structure of sars-cov-2 b.1.351 variant receptor binding domain in complex with neutralizing antibodies cs44 and cova1-16 |
|
39
|
231
|
7s5rH |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibodies cv07-287 and cova1-16 |
|
42
|
219
|
7s5pH |
Crystal structure of sars-cov-2 b.1.351 variant receptor binding domain in complex with neutralizing antibody cs23 |
|
34
|
126
|
7z1eFFF |
Nanobody h11-h4 q98r h100e bound to rbd |
|
36
|
230
|
7n4lH |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing human antibody wrair-2125. |
|
32
|
128
|
7z1dFFF |
Nanobody h11-h6 bound to rbd |
|
39
|
231
|
7s5qH |
Crystal structure of sars-cov-2 b.1.351 variant receptor binding domain in complex with neutralizing antibodies cs44 and cova1-16 |
|
49
|
196
|
7z1aA |
Nanobody h11 and f2 bound to rbd |
|
33
|
125
|
7z1aB |
Nanobody h11 and f2 bound to rbd |
|
40
|
196
|
7z1bA |
Nanobody h11-a10 and f2 bound to rbd |
|
39
|
224
|
7s5qB |
Crystal structure of sars-cov-2 b.1.351 variant receptor binding domain in complex with neutralizing antibodies cs44 and cova1-16 |
|
46
|
214
|
7s5rC |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibodies cv07-287 and cova1-16 |
|
45
|
196
|
7s5rA |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibodies cv07-287 and cova1-16 |
|
44
|
198
|
7s5qA |
Crystal structure of sars-cov-2 b.1.351 variant receptor binding domain in complex with neutralizing antibodies cs44 and cova1-16 |
|
46
|
214
|
7s5qC |
Crystal structure of sars-cov-2 b.1.351 variant receptor binding domain in complex with neutralizing antibodies cs44 and cova1-16 |
|
35
|
211
|
7n4lL |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing human antibody wrair-2125. |
